|
||||||||||||||||
|
|
||||||||||||||||
|
The EDCTP is a partnership between European and Developing Countries to perform clinical trials for the development of new drugs and vaccines against HIV/AIDS, Tuberculosis and Malaria. The need for global actions to combat HIV/AIDS, malaria and tuberculosis is a priority for poverty reduction in developing countries, as recognised by the United Nations, the G8 and the African Union. Addressing this priority, the
European Commission has launched its Programme for Action:
Accelerated action on HIV/AIDS, malaria and tuberculosis (COM (2001) 96:
en, fr
First pillar: Research and development On 16 June 2003 the Council and the
European Parliament adopted the decision on the Community
participation in the EDCTP programme (en,
fr
The EU Member States have created a non profit organisation (EDCTP_EEIG) to undertake the EDCTP programme in cooperation with developing countries. The governance of this organisation is specifically designed in order to make sure that the interests of developing countries will remain at the center of the objectives of the organisation. Second pillar: Access to medicines and trade For information on the second pillar, visit the Trade DG's web page on Access to Essential Medicines.Third pillar: Health and development For information on the third pillar, visit the Development DG's web page on Major Communicable Diseases. Contact point: Anne DEGRAND-GUILLAUD email: anne.degrand-guillaud @ec.europa.eu |
) in the context
of poverty reduction; it was adopted by the European Council on 15
May 2001. This unique and comprehensive programme is based on
three pillars: the research and development of specific global
public goods, the impact of existing interventions, and the
affordability of key pharmaceuticals and trade to tackle these
diseases at the national, regional and global level. |
|||
 |
 |
Background information |
|
 |
|||
|
|
|||
 |
|||
|
|
|||
|
|||
|
|
On-going research funded by the EC |
|
|
|||
|
|||
|
|||
|
|
|||
programme
(2002-2006)